Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $5.6 million.

  • Pulse Biosciences' Share-based Compensation rose 8836.35% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.3 million, marking a year-over-year increase of 12965.37%. This contributed to the annual value of $13.6 million for FY2024, which is 8919.37% up from last year.
  • As of Q3 2025, Pulse Biosciences' Share-based Compensation stood at $5.6 million, which was up 8836.35% from $5.2 million recorded in Q2 2025.
  • Over the past 5 years, Pulse Biosciences' Share-based Compensation peaked at $7.0 million during Q1 2021, and registered a low of $723000.0 during Q3 2022.
  • For the 5-year period, Pulse Biosciences' Share-based Compensation averaged around $3.0 million, with its median value being $2.1 million (2024).
  • Per our database at Business Quant, Pulse Biosciences' Share-based Compensation crashed by 7928.55% in 2022 and then skyrocketed by 34705.88% in 2023.
  • Pulse Biosciences' Share-based Compensation (Quarter) stood at $3.6 million in 2021, then tumbled by 79.29% to $748000.0 in 2022, then soared by 347.06% to $3.3 million in 2023, then skyrocketed by 103.14% to $6.8 million in 2024, then dropped by 17.31% to $5.6 million in 2025.
  • Its Share-based Compensation stands at $5.6 million for Q3 2025, versus $5.2 million for Q2 2025 and $5.7 million for Q1 2025.